Selective targeting of cytotoxic effector CD8+T cells via CX3CL1-conjugated mRNA lipid nanoparticles

被引：0
|
作者：
Corrigan, Angela [1 ]
Ngiow, Shin [1 ]
Pampena, Maria Betina [1 ]
Albertus, Amie [1 ]
Ni, Houping [1 ]
Wu, Vincent [1 ]
Kreider, Edward [1 ]
Wherry, E. John [1 ]
Weissman, Drew [1 ]
Betts, Michael [1 ]
机构：
[1] Univ Penn, Perelman Sch Med, Philadelphia, PA USA
来源：
JOURNAL OF IMMUNOLOGY | 2024年 / 212卷 / 01期
关键词：
D O I：
10.4049/jimmunol.212.supp.0243.6007
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] GENERATION OF FUNCTIONAL CD8+T CELLS IN VITRO BY DENDRITIC CELLS TRANSFECTED WITH GLYPI-CAN-3 MRNA
    O'Beirne, James
    Harrison, Philip M.
    HEPATOLOGY, 2008, 48 (04) : 396A - 396A
  • [32] Selective Targeting of Human Alloresponsive CD8+ Effector Memory T Cells Based on CD2 Expression.
    Lo, Denise J.
    Weaver, Tim A.
    Stempora, Linda
    Mehta, Aneesh K.
    Ford, Mandy L.
    Larsen, Christian P.
    Kirk, Allan D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 558 - 558
  • [33] Complement C3 deficiency enhances the effector function of CD8+T cells and inhibits tumour growth
    Pal, Pradipta
    Paul, Sourav
    Wahi, Praneet
    Meitei, Heikrujam Thoihen
    Sahu, Arvind
    Lal, Girdhari
    IMMUNOBIOLOGY, 2023, 228 (05) : 90 - 91
  • [34] 4-1BB is Superior to CD28 Costimulation for Generating Effector CD8+T Cells for Adoptive Immunotherapy
    Zhang, Hua
    Snyder, Kristen
    Suhoski, Megan
    Maus, Marcela
    Kapoor, Veena
    June, Carl H.
    Mackall, Crystal L.
    JOURNAL OF IMMUNOLOGY, 2007, 178
  • [35] Foxp1 Regulates Anti-tumor Effector Functions of CD8+T cells in Ovarian Cancer
    Stephen, Tom
    Takata, Hiroshi
    Feng, Xiaoming
    Wang, Haikun
    Rutkowski, Melanie
    Allegrezza, Michael
    Hu, Hui
    Conejo-Garcia, Jose
    JOURNAL OF IMMUNOLOGY, 2012, 188
  • [36] Enhanced effector function of CD8+T cells through thrombin activation of protease-activated receptor 1
    Smith, Mindy
    Hurley, Amanda
    Karpova, Tatiana
    Hasley, Rebecca
    Belkina, Natalya
    Shaw, Stephen
    Balenga, Nariman
    Druey, Kirk
    Nickel, Erin
    Packard, Beverly
    Imamichi, Hiromi
    Hu, Zonghui
    McNally, James
    Higgins, Jeanette
    Sneller, Michael
    Lane, Henry
    Catalfamo, Marta
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [37] Divalent MHC/IgG1 fusion protein induces effector function of CD8+T cells.
    Carey, B
    DeLay, M
    Milligan, G
    Strasser, J
    Chalk, C
    Hirsch, R
    FASEB JOURNAL, 2002, 16 (04): : A309 - A309
  • [38] Type 1 Diabetes Prevention in NOD Mice by Targeting DPPIV/CD26 Is Associated with Changes in CD8+T Effector Memory Subset
    Alonso, Nuria
    Julian, Maria Teresa
    Carrascal, Jorge
    Colobran, Roger
    Pujol-Autonell, Irma
    Rodriguez-Fernandez, Silvia
    Tenlente, Aina
    Fernandez, Marco Antonio
    Minarro, Antoni
    Ruiz de Villa, Maria Carmen
    Vives-Pi, Marta
    Puig-Domingo, Manel
    PLOS ONE, 2015, 10 (11):
  • [39] Bim and CX3CR1/granzyme B in circulating CD8+T cells are predictive biomarkers for PD-1 blockade therapy
    Zhu, Mojun
    Zhang, Henan
    Foster, Nathan R.
    Dong, Haidong
    Bekaii-Saab, Tanios S.
    Jaszewski, Brandy L.
    Boland, Patrick M.
    Overman, Michael J.
    Pedersen, Katrina
    McWilliams, Robert R.
    CANCER RESEARCH, 2020, 80 (16)
  • [40] Targeting SRSF1 improves cancer immunotherapy by dually acting on CD8+T and tumor cells
    Zhu, Gui-Qi
    Tang, Zheng
    Chu, Tian-Hao
    Wang, Biao
    Chen, Shi-Ping
    Tao, Chen-Yang
    Cai, Jia-Liang
    Yang, Rui
    Qu, Wei-Feng
    Wang, Yi
    Zhao, Qian-Fu
    Huang, Run
    Tian, Meng-Xin
    Fang, Yuan
    Gao, Jun
    Wu, Xiao-Ling
    Zhou, Jian
    Liu, Wei-Ren
    Dai, Zhi
    Shi, Ying-Hong
    Fan, Jia
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2025, 10 (01)
12345